Clinical Trial 49798

Washington, DC 20017




Help protect against RSV. 

Learn more about participating in the ConquerRSV Trial, a clinical trial for a potential vaccine to prevent respiratory syncytial virus (RSV) infection.

What is RSV?RSV is a common respiratory virus that infects the lungs and breathing passages. People most frequently associate RSV with the risk it brings to young children, but not many know the high risk it poses for older adults. RSV is the second leading cause of signifi cant respiratory tract illnesses in adults, behind only influenza (flu).

Is treatment available?There are currently no approved treatments or vaccines for RSV. Moderna is sponsoring a clinical trial for mRNA-1345, an investigational vaccine. Moderna is studying this vaccine to understand whether it can help your body’s immune system protect against RSV.

Interested in participating? Ask your healthcare provider or contact the research clinic listed below.

Who can join the ConquerRSV Trial?

This clinical trial is looking for adult volunteers. To join, you must be:

  • 60 years of age or olderIn good health
  • Certain chronic diseases such as heart failure and chronic obstructive pulmonary disease may be permissible
  • Primarily responsible for self-care(do not require a caretaker)

Qualified Participants May Receive:

You may be compensated for your trial-related time and travel.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.